Rocket Lab Stock’s New Reality: Two Competitors, One Rocket, and a $58 Billion Question
Published on 07/04/2026 at 16:25 | Redaktion boerse-global.de
The space investment landscape has shifted seismically in the span of a few weeks. SpaceX’s historic June 12 IPO on the Nasdaq turned the private giant into a public mega?cap, while Starfighters Space slid quietly into the Russell 3000 on June 29 via a passive index rebalance. For Rocket Lab, which long enjoyed a monopoly on publicly traded pure?play space exposure outside of Elon Musk’s empire, the new market dynamics are forcing a recalibration. The stock is now caught between two forces: the technical risks of its next?generation Neutron rocket and the gravitational pull of a much larger rival.
Rocket Lab shares have already felt the whiplash. After touching an all?time high of $150.23 on May 27, the stock has retreated to around $100 — a 33% drop that leaves the 52?week range stretching from $35.27 at the low to $151 at the high. Market capitalisation has settled at roughly $57–58 billion, still enough to keep the company in the established?player tier but increasingly vulnerable to any misstep.
That misstep could come from Neutron, the medium?lift rocket on which Rocket Lab is staking its next growth phase. Originally slated for 2024, the first flight now targets the fourth quarter of 2026. CEO Peter Beck has been blunt: anything short of a flawless orbit on debut is unacceptable. “An incomplete product will not roll to the pad,” he has stressed. The development cost, meanwhile, has ballooned from an initial estimate of $250 million to an expected $360 million by the end of 2025. Personnel alone burn $15 million per quarter, and any additional delay would inflate that burden further. A first?stage tank ruptured during a ground test early in 2026, forcing a design revision. Beck himself warns against over?confidence in smooth test campaigns.
Yet the bull case remains compelling. Rocket Lab already has paying clients lined up for Neutron, including a block?sale of multiple launches to an undisclosed customer — the largest single order in the company’s history. The total backlog stood at $2.2 billion at the end of the first quarter of 2026, with launch services accounting for 41% of that. A successful debut would open the door to the US government’s Lane?1 programme, a five?year contract vehicle worth $5.6 billion. Analysts have responded with near?universal optimism: all 17 covering the stock rate it a Buy, with a consensus price target of $103.
Should investors sell immediately? Or is it worth buying Rocket Lab USA?
The bear case, however, is equally visible. At $57–58 billion in market cap, Rocket Lab trades at 62 times expected annual revenue on a forward basis and 131 times trailing sales — steeper multiples than even SpaceX, which commands a 94 times trailing P/S ratio. That lack of valuation cushion leaves no room for disappointment. If Neutron’s ground tests reveal further hardware flaws and push the maiden flight into 2027, the stock’s high?flying multiple would come under savage pressure, and the prospect of new government awards would recede.
SpaceX’s own post?IPO volatility provides a cautionary tale. After surging to a high of $225.64 on June 16, the stock slid back to about $153 by late June — still above the $135 offer price but well shy of the euphoric peak. Several analysts have already turned sceptical: CFRA initiated coverage with a Sell rating and a $115 target, citing “overly ambitious growth strategy and stretched valuation expectations.” Morningstar pegs fair value at just $63 a share, labelling the stock “overvalued.” That scepticism may paradoxically work in Rocket Lab’s favour, keeping a lane open for a proven alternative with a track record of successful launches.
For now, the test stand on Wallops Island, Virginia, is the only compass that matters. Engineers are outfitting Neutron with flight electronics and fluid systems in Middle River before shipping it to the pad for integrated system tests. If those checks proceed without major structural failures, the market is likely to reward incremental progress with renewed confidence. But any new hardware issues would trigger a quick reassessment. The landing ship for Neutron’s first?stage recovery won’t be ready until the second flight, so recoverability is not a factor yet.
Rocket Lab USA at a turning point? This analysis reveals what investors need to know now.
The ultimate prize is orbital success in the fourth quarter of 2026. A clean ascent would validate the $2.2 billion backlog, unlock access to the Lane?1 contract, and potentially open the door to new all?time highs. Until then, Rocket Lab’s share price will rise and fall on the rhythm of parts hitting the test stand — and on whether investors believe the company can thrive in a market that suddenly has two more publicly traded players.
Ad
Rocket Lab USA Stock: New Analysis - 4 July
Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
